BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8557967)

  • 1. Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions.
    Böhm M; Lee M; Kreutz R; Kim S; Schinke M; Djavidani B; Wagner J; Kaling M; Wienen W; Bader M
    J Hypertens; 1995 Aug; 13(8):891-9. PubMed ID: 8557967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
    Bader M; Zhao Y; Sander M; Lee MA; Bachmann J; Böhm M; Djavidani B; Peters J; Mullins JJ; Ganten D
    Hypertension; 1992 Jun; 19(6 Pt 2):681-6. PubMed ID: 1592468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
    Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
    Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade.
    Böhm M; Lippoldt A; Wienen W; Ganten D; Bader M
    Mol Cell Biochem; 1996; 163-164():217-21. PubMed ID: 8974060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats.
    Ohta K; Kim S; Wanibuchi H; Ganten D; Iwao H
    Circulation; 1996 Aug; 94(4):785-91. PubMed ID: 8772703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.
    Gross V; Lippoldt A; Bohlender J; Ganten D; Ganten U; Luft FC
    Exp Nephrol; 1996; 4 Suppl 1():20-6. PubMed ID: 9001893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
    Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
    J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of renal failure after subtotal nephrectomy in transgenic rats carrying an additional renin gene [TGR(mREN2)27].
    Wagner J; Klotz S; Haufe CC; Danser JA; Amann K; Ganten D; Ritz E
    J Hypertens; 1997 Apr; 15(4):441-9. PubMed ID: 9211179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.
    Bachmann S; Peters J; Engler E; Ganten D; Mullins J
    Kidney Int; 1992 Jan; 41(1):24-36. PubMed ID: 1593860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
    Zhuo J; Ohishi M; Mendelsohn FA
    Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal renin expression and its role in ren-2 transgenic rats TGR(mREN2)27.
    Peters J; Ganten D
    Horm Metab Res; 1998; 30(6-7):350-4. PubMed ID: 9694562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene.
    Baltatu O; Cayla C; Iliescu R; Andreev D; Jordan C; Bader M
    J Am Soc Nephrol; 2002 Nov; 13(11):2681-7. PubMed ID: 12397037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects.
    Langheinrich M; Lee MA; Böhm M; Pinto YM; Ganten D; Paul M
    Am J Hypertens; 1996 May; 9(5):506-12. PubMed ID: 8735183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.
    Lee MA; Böhm M; Kim S; Bachmann S; Bachmann J; Bader M; Ganten D
    Hypertension; 1995 Apr; 25(4 Pt 1):570-80. PubMed ID: 7721400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.
    Peters J; Münter K; Bader M; Hackenthal E; Mullins JJ; Ganten D
    J Clin Invest; 1993 Mar; 91(3):742-7. PubMed ID: 8383701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats. TGR(mREN2)27.
    Peters J; Hilgers KF; Maser-Gluth C; Kreutz R
    Clin Exp Hypertens; 1996 Oct; 18(7):933-48. PubMed ID: 8886477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27.
    Zhao Y; Bader M; Kreutz R; Fernandez-Alfonso M; Zimmermann F; Ganten U; Metzger R; Ganten D; Mullins JJ; Peters J
    Am J Physiol; 1993 Nov; 265(5 Pt 1):E699-707. PubMed ID: 8238495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic dexamethasone treatment suppresses hypertension development in the transgenic rat TGR(mREN2)27.
    Djavidani B; Sander M; Kreutz R; Zeh K; Bader M; Mellon SH; Vecsei P; Peters J; Ganten D
    J Hypertens; 1995 Jun; 13(6):637-45. PubMed ID: 7594421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.